drugset / Trial / NCT02176512
Telmisartan/Hydrochlorothiazide (HCTZ) Fixed Dose Combination Compared to Its Monocomponents in Healthy Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
Study to demonstrate the bioequivalence of telmisartan and HCTZ administered as fixed dose combination in comparison to the single unit formulations
Timeline
- Start
- 1998-09
- Primary completion
- 1998-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydrochlorothiazide | Unknown | 12.5 mg | Oral |
| Subject | Telmisartan | Other / unclassified | 80 mg | Oral |
Indications
No indication recorded.